JHM Biopharma

Hangzhou, China · Founded 2020 · Privately Held (backing)

Provider and developer of biological proteins used as medications. JHM Biopharma is based in Hangzhou, China and was founded in 2020. Its last reported valuation was $160 million in May 2024. It has raised $84.8 million.

Last reported valuation

$159.7M

Oct 2026

Priced at

—

Total raised

$84.8M

Last round

—

How much has JHM Biopharma raised?

$84.8Macross 0 recorded rounds

Free account

More of JHM Biopharma with a free account

·The complete investor list: 13 names
·Watch JHM Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

JHM Biopharma investors

13 investors are on record for JHM Biopharma, including Suzhou Oriza Holdings Corporation, SDIC Unity Capital, Shanghai Guofang Private Equity Fund Management Company and 3E Bioventures Capital.

For fundraisers

Raising for a company like JHM Biopharma?

13 investors have backed JHM Biopharma.

See all 13 investors →

Frequently asked about JHM Biopharma

How much has JHM Biopharma raised?: JHM Biopharma has raised $84.8M in total across 0 recorded funding rounds.